ALG3 and ovarian cancer: Collectively, these data demonstrate that ALG3 was abnormally highly expressed in ovarian cancer, and the altered expression of ALG3 would explain the changes in mannosyl glycan structures associated with the metastatic potential and poor prognosis in ovarian cancer.